Inventor · disambiguated record
Nicholas B. La Thangue
Also filed as: LA THANGUE NICHOLAS · LA THANGUE NICHOLAS B · LA THANGUE NICHOLAS BERRIE
7 granted patents·5 pending applications·8 citations·filing 1995–2022
75Inventor score
Files withARGONAUT THERAPEUTICS LTD3CELLERON THERAPEUTICS LTD3ISIS INNOVATION3LA THANGUE NICHOLAS1LA THANGUE NICHOLAS B1
Top patents by PatentIndex Score
12 records- 0183US11485731B2Compounds and methods useful in the treatment of a PRMT5-mediated disorderARGONAUT THERAPEUTICS LTD·Filed 2018·Granted Nov 1, 2022·5 cites·20 claims
- 0266US8784806B2Screening methodLA THANGUE NICHOLAS B·Filed 2007·Granted Jul 22, 2014·2 cites·22 claims
- 0361US9347103B2Screening methodISIS INNOVATION·Filed 2014·Granted May 24, 2016·0 cites·17 claims
- 0456US10012652B2Screening methodISIS INNOVATION·Filed 2016·Granted Jul 3, 2018·0 cites·10 claims
- 0555US2024287036A1Compounds useful in the treatment or prevention of a prmt5-mediated disorderARGONAUT THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0651US12453725B2Treatment of inflammatory diseaseCELLERON THERAPEUTICS LTD·Filed 2020·Granted Oct 28, 2025·0 cites·19 claims
- 0746US2016069887A1Biomarkers for prognosisISIS INNOVATION·Filed 2014·Application pending·0 cites
- 0845US2022118070A1Cancer therapy by modifying neoantigen expressionLA THANGUE NICHOLAS·Filed 2020·Application pending·0 cites
- 0945US2024180890A1Vaccine adjuvantCELLERON THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1042US2021093625A1Combination therapyCELLERON THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1137US11274098B2Tricyclic compounds for use in treatment of proliferative disordersARGONAUT THERAPEUTICS LTD·Filed 2018·Granted Mar 15, 2022·0 cites·16 claims
- 1232US5871901AAssay for inhibitors of DP-1 and other DP proteinsMEDICAL RES COUNCIL·Filed 1995·Granted Feb 16, 1999·1 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Nicholas B. La Thangue files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →